x

¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Ayuda - - Regístrese - Teléfono 902 888 740
Buscar en

Indexada en:

Index Medicus Medline, IME, Embase, Bibliomed, EMBASE/Excerpta Medica, Alert, International Pharmaceutical Abstracts, ADIS LMS Drug Alert, Inside Conferences, SCOPUS

Métricas

  • SCImago Journal Rank (SJR):0,21
  • Source Normalized Impact per Paper (SNIP):0,379
Farm Hosp 2005;29:26-9 - DOI: 10.1016/S1130-6343(05)73632-1
Utilización de medicamentos en una UCI neonatal: estudio prospectivo
R. López Martíneza, M J. Cabañas Poya, M. Oliveras Arenasa, S. Clemente Bautistaa
a Secci??n de Farmacia Maternoinfantil. Hospital Universitari Vall d.Hebron. Barcelona
Resumen
Introduction: Many drugs prescribed in pediatric units do not meet the conditions of use defined in their corresponding prescription information sheets, or their use has not been approved by the Spanish Health Authorities. The lack of clinical trials in children, and of adequate dosage forms, reduces drug safety, assuming both the physician and the pharmacist the responsibility for the drug use. Objective: To assess drug prescription status within a neonatal intensive care unit in a third-level hospital. Material and methods: A 3-months prospective study was performed, and information was collected from all admitted children along four time periods. Sixty-one complete therapies were evaluated, with a total of 236 drugs prescribed. Fifty percent were ¿off-label¿, 13% were ¿unlicensed¿, and 37% were correctly used. Conclusions: These figures resemble those from, similar studies carried out in other European hospitals. This is therefore a common practice resulting from the need to treat. Health authorities should encourage clinical trials so that drug therapies for children become evidence-based.
Palabras clave
Neonato, Fármacos ¿unlicensed¿, Fármacos ¿off-label¿, UCI neonatal, Utilización de medicamentos
Keywords
Newborn, Unlicensed drugs, Off-label drugs, Neonatal ICU, Drug use
El Texto completo solo está disponible en PDF